#Cleanx company software#

Although frustration may play a role in a client’s decision to continue with CGM, placing another sensor is easy and any data collected have value. 19,20 In this author’s experience, finding a patient that will tolerate a monitor placed between the shoulder blades is a 50:50 proposition: About half of the cats get “tired” of the monitor and figure out ways to dislodge the sensor at some point during the 14-day period. This one attribute of CGM-the capability of the owner to recognize that low blood sugar is imminent, become adept in realizing trends, and have the confidence to self-manage a stressful event-is one of the most important of the unexpected benefits.įeline patients present a specific challenge when using CGM. In the event of hypoglycemia, timely therapy with an exogenous oral source of calories can prevent an emergency situation. Should an absolute value be required that is beyond the monitor’s high level of confidence (>500 mg/dl), the clinician can get that through conventional means. Severe persistent hyperglycemia (>300 mg/dl) will be detected by CGM. Outside these limits, the sensor will read “Lo” or continue to report 500 mg/dl, even though values may exceed that amount. 12-18 Abbott states that reliability is highest between 40 and 500 mg/dl (CGM package insert). 11 Continuous glucose monitors measure the interstitial glucose levels, which closely mimic blood glucose levels. This is an advantage when practicing during a pandemic.Ĭoncerns regarding reliability have been addressed. This author has managed cases beginning with the purchase of a monitor and ending with resolution of a dysregulated diabetic patient without any hands-on contact at all-strictly email and telephone conversations. Client concerns over the well-being of their pets are common for patients with diabetes, yet the reassurance that clients derive from knowing the numbers often gives them confidence and relief. The pet owner has access to real-time data as well. The response to adjustments in dosage be tracked, and any problems with regulation can be identified and addressed in real-time. This system allows remote access by the veterinarian to manage the case.

#Cleanx company software#

Within minutes after monitor placement, the Abbott software begins to generate curves that collect a data point every minute for up to 14 days. Once insulin is started, a prescription to any pharmacy will allow the client to purchase the FreeStyle Libre monitor, and its package insert includes a link to the software on the Abbott website. A reader must be purchased if the owner does not own a smartphone. Use of a monitor that can be linked to a smartphone provides real-time accessibility to glucose levels in dogs and cats without the purchase of the reader. However, the general veterinary population can also use this affordable and simple treatment option. 6-10 Use of CGMs is still largely limited to veterinary teaching hospitals, specialty clinics, and the occasional private practice. However, in this author’s experience, it was the unexpected benefits to the owner and patient that made the difference.ĬGM in veterinary medicine has been described as early as 1993, 5 with research papers and reference articles becoming more prominent within the last 5 years. 4 These problems reveal the most obvious benefit of continuous glucose monitoring (CGM): Providing the clinician with an accurate picture of the blood glucose patterns in the patient 24 hours a day for up to 14 days. Home sampling results using an AlphaTRAKglucometer are owner-dependent and often lead to stress in both owner and patient, which for certain patients can have clinical significance. 3 In-hospital sampling rarely collects more than 12 data points during a 12-hour workday. 2 It is well documented that blood glucose curves vary from day to day in the same patient. Typically, attaining a blood glucose curve means collecting a blood sample every 1 to 2 hours, either with a hospitalized patient using conventional venipuncture or using a monitor such as AlphaTRAK. Until recently, it has been advisable to perform a blood glucose curve to determine whether adjustments in the initial dose were needed. 1 Following an initial diagnosis and institution of insulin and dietary therapy, patient monitoring is key to finding optimal insulin. Treatment for diabetes relies on exogenous insulin therapy, in most cases, to reverse existing glucose toxicity and attempt to achieve near normoglycemia. Canine and feline diabetes is an endocrinopathy most often caused by an insulin-dependent etiology similar to type 1 diabetes in humans.